Table 1.
Survivor characteristics.
| Patient ID | 0 | 13 | 15 | 17 | 36 |
|---|---|---|---|---|---|
| Gender | F | F | M | M | F |
| Age at diagnosis | 79 | 57 | 72 | 52 | 61 |
| OS (day) | 1105 | 2647 | 892 | 795 | 2476 |
| Thyroid biopsy | Yes | Yes | No | No | No |
| Biopsy result | ATC | ATC | / | / | / |
| Stage (AJCC) | IVB | IV A | IV B | IV A | IV B |
| Metastasis at diagnosis | Muscle | No | Parathyroid | No | Lymph node |
| Tumor size (cm)a | 4 | 6 | 4 | 6 | 5 |
| Surgery | Yes | Yes | Yes | Yes | Yes |
| Radical Surgery | Yes | Yes | Yes | Yes | Yes |
| Radiotherapy | Yes | No | Yes | No | Yes |
| Radiotherapy Time | 27 | / | 33 | / | 23 |
| Chemotherapy | No | No | No | No | Yes |
| Chemotherapy Regimen | / | / | / | / | EPI, DDP |
OS, overall survival; AJCC, American Joint Committee on Cancer; EPI, epirubicin; DDP, cisplatinum.
a
Tumor size using maximum diameter.